News
0102030405
A record of major events in the company
2023-11-28
In 2000 years
Tianjin Shengao Cosmetics Co. , Ltd. was established, began to focus on cosmetics OEM business
In 2008 Years
Tianjin Shengao Cosmetics exploited the American market successfully, covering Asia, Europe, North America and Oceania
In 2014 Years
Tianjin Shengao cosmetics become the board member of Tianjin Network Chamber of Commerce
In 2017 Years
Hebei Shengao Cosmetics co.,ltd was established, and the establishment of the Joint Application Research and Development Center
In 2018 Years
Shengao became a member of China Association of Traditional Chinese medicine and the national chronic disease drug food homologous research experimental base, the layout of large health industry
In 2019 Years
Participating in high-tech projects and receiving visits from Handan's participation group
Signed a strategic partnership framework agreement with the Republic of Korea Sales Beauty Kovea co.,ltd, served as Hebei high-tech Enterprise Association vice-chairman unit
In 2020 years
Hebei Shengao was awarded high-tech Enterprise of Hebei province
In 2021 years
ReceiveHebei provience delegation to visit and receive CCTV influence time interview
R & D Team
High-end skin care products R & D Team
He previously served as director of research and development for Amore (Pacific) joint-stock company skincare products
Professor, School of Beauty Science, Suwon University
Director of the Beauty Science Research Center, Suwon University
President of the Korea Institute of New Substances in Life Sciences, World Association for Beauty Education
President of the World Association for Beauty Education
President of japan-china Health Food and cosmetics promotion association
Professor of Beauty Industry, Gyeonghee University Business School, Korea
Research and development cooperation institution
Hebei Shengao should take the initiative to go out and establish in-depth cooperative relations with many research institutions around the world to help Shengao develop new products continuously to meet the increasingly diverse individual needs of consumers
Company executives and R & D staff visited the US and Korea to have in-depth technical exchanges with the us-based Acer pharmaceutical, Washington State University and the Korean Institute of Life Sciences New Substances